Chien-Chien Jacques Appointed CFO at Rooster Bio RoosterBio, a Frederick-based leader in stem cell and exosome technologies, has appointed Chien-Chien “CC” Jacques as its new CFO, where she will oversee [….]
U.S. FDA Grants Theradaptive IDE Approval for Phase I/II Clinical Trials
Published on :U.S. FDA Grants Theradaptive IDE Approval for Phase I/II Clinical Trials
Philadelphia Biotech Executive Ready to take Promising Stem Cell therapy to the Clinic
Published on :Kyttaro Therapeutics COO, Eric Hacheral, announces fundraising efforts and intention to establish a Philadelphia-based R&D operation to quickly take their lead product into Phase I-II trials in Germany and the US.
Over $8M in 2020 Stem Cell Funding Awards Continue to Fuel Maryland’s Leading Cell Therapy Industry
Published on :Over $8M in 2020 Stem Cell Funding Awards Continue to Fuel Maryland’s Leading Cell Therapy Industry The Maryland Stem Cell Research Commission (The Commission) recently announced over $7M in Maryland [….]